Advertisement

Topics

Final modified framework for assessing ultra-rare disease drug value released by ICER

09:35 EST 14 Nov 2017 | thePharmaLetter

Following a nine-month public process, the USA’s Institute for Clinical and Economic Review (ICER)…

Original Article: Final modified framework for assessing ultra-rare disease drug value released by ICER

NEXT ARTICLE

More From BioPortfolio on "Final modified framework for assessing ultra-rare disease drug value released by ICER"

Advertisement
Quick Search
Advertisement
Advertisement